Not all hypertension drugs are created equal, reports big-data study
For those with extremely high blood pressure, or hypertension, there are many initial medication options — so many that it can be hard to know which one to use. Now, a Yale-coauthored paper in Lancet provides more information about the relative safety and effectiveness of different hypertension drugs in order to inform this critical treatment decision. The study reveals that angiotensin converting enzyme (ACE) inhibitors may not be the best choice for initial treatment.
How Non-Profit Hospitals Are Driving Up The Cost Of Health Care
Last year, when New York Governor Andrew Cuomo was battling to win the Democratic primary, his campaign solicited a donation from the Greater New York Hospital Association, according to a recent report from The New York Times. The hospital lobbying group gave over $1 million to the New York State Democratic Party. And not long after, according to the Times, "the state quietly authorized an across-the-board increase in Medicaid reimbursement rates." The increase is expected to cost taxpayers around $140 million a year.
We Found Over 700 Doctors Who Were Paid More Than a Million Dollars by Drug and Medical Device Companies
Back in 2013, ProPublica detailed what seemed a stunning development in the pharmaceutical industry’s drive to win the prescription pads of the nation’s doctors: In just four years, one doctor had earned $1 million giving promotional talks and consulting for drug companies; 21 others had made more than $500,000.
New Faculty Friday: Jamie Tam, tobacco use expert, modeling scientist, country western dancer
Today we spotlight Jamie Tam, assistant professor in the Department of Health Policy and Management. Tam has a Ph.D. in health services organization and policy (2018) and an M.P.H. in health management and policy (2012) from the University of Michigan. She earned a B.S. with honors from Stanford University in 2010. Prior to coming to Yale, Tam served one year as a National Academy of Medicine Fellow at the U.S. Food and Drug Administration’s Center for Tobacco Products.
Yale Investigators Receive NIH HEAL Grants to Study Solutions to the Opioid Crisis
Yale researchers representing a range of disciplines have been awarded grants through the National Institutes of Health (NIH) Helping to End Addiction Long-term Initiative (HEAL). This national effort provides $945 million in total funding to support a variety of research projects that tackle the opioid addiction and overdose crisis.
Yale Investigators' Lead Grant Awarded as Part of the NIH HEAL Initiative on Opioids
Dr. Gail D’Onofrio, Professor of Emergency Medicine and Public Health and Dr. David Fiellin, Professor of Medicine, Emergency Medicine and Public Health are lead investigators in a $25.5 Million study being conducted by the National Drug Abuse Treatment Clinical Trials Network’s New England Consortium Node.
Yale Launches Comprehensive DNA Sequencing Project, With Aim of Predicting, Preventing, and Treating Gene-related Diseases
Generations, a collaboration between Yale School of Medicine and Yale New Haven Health System, is one of the largest DNA sequencing projects of its kind in the United States.
Why it's so hard for patients to access their medical records
In health care today, there's a great emphasis on amassing large databases of patient medical records, but for many patients the process of accessing their own records can be challenging—and it's completely "at odds with your federal rights," Harlan Krumholz, a cardiologist and professor at Yale School of Medicine, writes for NPR's "Shots."
Blacks, Poor At Higher Risk Of Heart Disease; Overall Death Rate Falls
The death rate from heart disease plummeted nationally over several decades for all racial and ethnic groups, but the rate of decline has slowed slightly and African Americans and low-income individuals are still at a higher risk of developing the disease and dying from it, according to a report from the National Center of Health Statistics.
How 5G technology is changing the healthcare industry
The advent of the 5G era opens up limitless possibilities in improving lives and one sector that could see monumental advances is healthcare. CGTN's Mike Walter spoke with Chen Xi for more on how 5G technology can benefit the industry. Chen is an Assistant Professor at Yale School of Public Health.